Bringing decades of experience and strategic thinking to lead the members of the Mauna Kea Technologies team.
Mauna Kea Technologies has assembled a team of experts from various domains to overcome the hurdles that have impeded clinical research and treatment for decades. Along with their exceptional technical expertise, each member of our management team possesses the strong team building and organizational skills that enable Mauna Kea Technologies’ multidisciplinary approach to success and innovation.
SACHA LOISEAU, Ph.D.
President and CEO. Co-Founder
Sacha founded Mauna Kea Technologies in 2000 and has been the CEO ever since.
A co-inventor of the probe-based Confocal Laser Endomicroscopy technology, he piloted the development of the Cellvizio product line, raising over € 32 million with private investors until taking the company public in July 2011 on the NYSE Euronext Paris stock exchange.
In 2013, Sacha was named the co-lead of France's Re-industrialization Plan for Medical Devices by the French President and then a member of the Committee for the Future of Medicine. Sacha has served as a mentor to the Polytechnique-Stanford Ignite Program for young MedTech entrepreneurs for several years. Sacha was instrumental in the foundation of the association Medtech in France, of which he is Vice-President.
Sacha started his career at the National Center for Space Studies (CNES) in Toulouse and at the Paris Observatory, then joined NASA's Jet Propulsion Laboratory (JPL) in Pasadena, California, as a research scientist. Sacha has a Ph.D. in Astrophysics and Optical Instrumentation and is the author of multiple scientific articles and holds 7 international patents.
Chief Operating Officer
Seasoned medical device executive with decades of experience in U.S. and global markets strengthens global leadership team
John Soto has joined the team as Mauna Kea’s new Chief Operating Officer, responsible for Global Operations and Commercial Execution. John has more than 25 years' experience in the medical device industry. Prior to joining MKT he served as Executive Vice President and Chief Commercial Officer at AngioDynamics, a NASDAQ-listed global medical device company, where he oversaw the Company's global commercial execution and strategy, including international distribution partnerships. Prior to AngioDynamics, John's earlier roles include senior leadership positions with Smith & Nephew, RITA Medical Systems, Computer Motion and U.S. Surgical. John served in the British Royal Navy where he earned a degree in electronic engineering and studied medical marketing at the University of California at Los Angeles.
Chief Financial Officer
Benoît brings a wealth of financial and change-management experience from a range of companies that saw rapid growth.
After an initial experience of working for BNP Paribas in Indonesia, Benoît launched his career as a financial controller for IBM and Bouygues. He then started a long and successful streak of jobs in the telecom business, working from 1997 for Cegetel as head of business planning, then in 2000 for LDCom where he was at the heart of the financial team dealing with the explosive growth from €100M to €2,500M revenue in 5 short years. After 2006, Benoît moved on from the telecom business and decided to apply his extensive experience to a variety of different domains, taking on transition and change-management roles as a CFO in various companies such as Imakys Communications, A&O Systems, Promovacances, Leosphere, Movitex or Wonderbox. Benoît is a graduate from ICN Business School in Nancy, France.
Global Director of Sales
Bruno has a rich, international background garnered from his studies in Lebanon, Italy and France where he became fluent in four languages.
Bruno started his career as an Export Area Manager for Sapag, a division of Saint-Gobain, then worked 15 years for Tyco Fire & Building Products where he was appointed General Manager of Asia-Pacific. In January of 2009, Bruno joined Mauna Kea Technologies with a mission to develop the Asia-Pacific market for Cellvizio. Since 2010, Bruno has been responsible for the deployment of Cellvizio in all territories and he now leads the global sales effort for Mauna Kea Technologies from Boston.
President, North America and Chief Development Officer
Chris joined Mauna Kea Technologies in January of 2008 as the President of its U.S. subsidiary and brings 23 years of experience in the industry.
Chris worked as a Senior Healthcare Analyst at Genesis Merchant Group, an investment banking firm based in San Francisco during the mid-90's. He then joined Teleflex Medical where he was appointed Vice President and General Manager for the surgical instrument business. In 2003, Chris became the President and the CEO of Surgical Services, Inc. Chris holds an MBA from the University of San Diego, an M.S. in Biomedical Engineering from Drexel University, Philadelphia and a B.S. in Mechanical Engineering from Lehigh University in Pennsylvania.
Global Director of Marketing and OEM Leader
Sebastien brings more than 15 years of experience in the fields of surgical instrumentation and OEM marketing
A seasoned medical device marketing executive, Sebastien held various positions in product management, product development, direct and B2B marketing management at W.O.M., a major OEM provider of surgical and medical instruments. Based in Orlando for the past 15 years, Sebastien successfully launched and grew market shares for various product lines and acquired direct sales experience as well in the field of breast cancer care and laser lithotripsy.
Sebastien is Pragmatic Marketing Certified and holds a Biomedical Engineer degree from Polytech Marseille.
Christophe BAILLEUL, PhD, MBA
Vice-President Clinical Affairs, Health Economics and Market Access
Christophe joined Mauna Kea Technologies in 2015 and brings a wealth of clinical knowledge to the company with more than 25 years of international experience in the biotech and medical device sectors.
Christophe started his career in a French biotech startup affiliate of the National Blood Transfusion Foundation in the late 80s. He then spent 5 years in Germany as a research and quality assurance manager in a young CRO, PRA International. He also worked in the clinical development field at Ela Medical, which is part of Sorin Group. From 2002 on he was based in Belgium as the VP of Clinical Affairs and Health Economics of the International Division at St. Jude Medical.
Christophe holds multiple academic degrees including, an engineering degree from the Université de technologie de Compiègne in France, an MSc in blood transfusion and immunology, a PhD in immuno-biotechnologies and an MBA from ESSEC in Paris, France.
FRANÇOIS LACOMBE, Ph.D.
Chief Scientific Officer
François is a world-renowned scientist and the author of more than 150 scientific papers and 10 patents.
He spent 14 years working on major international astronomy projects such as ISOCAM, the Infrared SPace Observatory (ISO) satelite's on board camera, ADONIS, the first multi-user adaptive optics system and most recently NAOS, an adaptive optics system for the Very Large Telescope in Chile. François has been collaborating with Mauna Kea Technologies since its inception. François is a graduate of the École Normale Supérieure in Paris and holds a Ph.D. in Astrophysics.
VÉRONIQUE DENTAN, Ph.D.
Director of Operations
Véronique has invaluable experience in R&D, product design and engineering management on innovative products.
She began her carreer at the Thales Central Laboratory, first as a research engineer, then as Head of the Organic Materials laboratory. Véronique then went to Photonetics, a telecom company sold to GN NetTest in 2000, where she worked as Chief Technical Officer setting up and developping the R&D and engineering departments for Optical Components. Before joining Mauna Kea Technologies, Veronique also spent 2 years at IXsea, a French Company specialized in fiber-optics based inertial sensors where she was responsible for the OCTANS gyrocompass product line. Véronique is a graduate of the École Supérieure d'Optique in France and holds a Ph.D. in Non-Linear Optics.
|See how it all started, from Stars to Cells.|